In the Asia-Pacific medical devices industry, there were 29 M&A deals announced in Q2 2023, worth a total value of $973.9m, according to GlobalData’s Deals Database. The $738m acquisition of eoflow by medtronic was the industry’s largest disclosed deal. A thorough analysis of the disruptive themes, the M&A activity and most notable deals are included in GlobalData’s Medical Devices Industry Mergers and Acquisitions Deals by Top Themes report. Buy the report here.
Smarter leaders trust GlobalData
In value terms, M&A activity in Asia-Pacific increased by 50% in Q2 2023 compared with the previous quarter’s total of $651m and fell by 10% as compared to Q2 2022. Related deal volume decreased by 6% in Q2 2023 versus the previous quarter and was 7% higher than in Q2 2022.
The top-ranked financial advisors supporting these M&A deals in Asia-Pacific in Q2 2023 were Wodehouse Capital Advisors Private; Goldman Sachs Group; JPMorgan Chase & Co with 2, 1, 1 deals respectively.
The top-ranked legal advisors supporting these M&A deals in Asia-Pacific Q2 2023 were Khaitan & Co; Ropes & Gray; Bae, Kim & Lee with 3, 2, 1 deals respectively.
For further understanding of GlobalData's Medical Devices Industry Mergers and Acquisitions Deals by Top Themes, buy the report here.
Premium Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
